AI is transforming research. These AI tools for research will help you keep up with the times and take your research to the next level.
Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
Despite data gaps in many countries, the burden of sickle cell disease, especially in west and central Africa, underscores ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results